A simple way to guarantee an adequate flow of long-run, sustained funding for health surveillance and disease control, and to prepare for the next novel virus in the world’s poor countries, is to create an endowment dedicated to that purpose. A $10 billion endowment could generate income of $500 million a year.
CGD Policy Blogs
In a surprise move Tuesday, the US Treasury announced its intention to nominate Mauricio Claver-Carone to the presidency of the Inter-American Development Bank (IDB), a role traditionally held by a citizen of a borrowing member country from the region.
The global race to develop a COVID-19 vaccine is far from conventional. An effective vaccine would offer one of the few credible exit paths from the world’s worst public health and economic crisis in recent history. Is a pull for R&D essential or optional?
The unilateral ultimatum issued by President Donald Trump to the World Health Organization—"reform or else” in 30 days—raises the real possibility of a WHO without funds or governance participation from the United States. What would that mean in practice?
This is the first in a series of blogs in which we’ll focus on non-COVID-19 excess deaths caused by the response to COVID-19, part of a larger project at CGD to help policymakers minimize the indirect health impacts of the pandemic.
Every country faces the same fundamental challenge in the face of the COVID-19 pandemic. Their economies and societies cannot fully return to “normal” until we have a safe and effective vaccine. And achieving that goal quickly is not easy. We see four big problems.
As low- and middle-income countries are hit by the health and economic effects of COVID-19, the international community is working to mobilize billions of dollars in grants, loans, and debt relief. At the moment, it is difficult to get a full picture of the funding on offer, to whom it is given, and how it will be used.
Maintaining Essential Services in the Time of COVID-19: Vaccination Delivery in Low- and Middle-Income Countries
As we observe World Immunisation Week, the implications of COVID-19’s spread for routine childhood vaccination delivery are already becoming clear.
In the response to the COVID-19 pandemic, it is now evident that many of the public health and hospital-based interventions deployed by high-income countries may be ineffective or infeasible in low- and middle-income countries. We suggest a different order of priority for immediate next steps.
Yesterday we sent the following letter to U.S. Representative Nancy Pelosi (D-Calif.), the House Speaker, and U.S. Sen. Mitch McConnell (R-Ky.), the Senate Majority Leader, outlining measures that could be included in upcoming Congressional emergency legislation related to combating the coronavirus in developing countries. The text of the letter follows:
Dear Speaker Pelosi and Senator McConnell: